639 related articles for article (PubMed ID: 9393761)
1. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents.
Kokkinakis DM; Ahmed MM; Delgado R; Fruitwala MM; Mohiuddin M; Albores-Saavedra J
Cancer Res; 1997 Dec; 57(23):5360-8. PubMed ID: 9393761
[TBL] [Abstract][Full Text] [Related]
2. Sensitization of pancreatic tumor xenografts to carmustine and temozolomide by inactivation of their O6-Methylguanine-DNA methyltransferase with O6-benzylguanine or O6-benzyl-2'-deoxyguanosine.
Kokkinakis DM; Ahmed MM; Chendil D; Moschel RC; Pegg AE
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3801-7. PubMed ID: 14506174
[TBL] [Abstract][Full Text] [Related]
3. Treatment of human brain tumor xenografts with O6-benzyl-2'-deoxyguanosine and BCNU.
Schold SC; Kokkinakis DM; Rudy JL; Moschel RC; Pegg AE
Cancer Res; 1996 May; 56(9):2076-81. PubMed ID: 8616853
[TBL] [Abstract][Full Text] [Related]
4. O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy.
Silber JR; Blank A; Bobola MS; Ghatan S; Kolstoe DD; Berger MS
Clin Cancer Res; 1999 Apr; 5(4):807-14. PubMed ID: 10213216
[TBL] [Abstract][Full Text] [Related]
5. Modulation of 1,3-bis-(2-chloroethyl)-1-nitrosourea resistance in human tumor cells using hammerhead ribozymes designed to degrade O6-methylguanine DNA methyltransferase mRNA.
Zhang Q; Ohannesian DW; Kreklau EL; Erickson LC
J Pharmacol Exp Ther; 2001 Jul; 298(1):141-7. PubMed ID: 11408535
[TBL] [Abstract][Full Text] [Related]
6. O6-methylguanine-DNA methyltransferase activity in adult gliomas: relation to patient and tumor characteristics.
Silber JR; Bobola MS; Ghatan S; Blank A; Kolstoe DD; Berger MS
Cancer Res; 1998 Mar; 58(5):1068-73. PubMed ID: 9500473
[TBL] [Abstract][Full Text] [Related]
7. Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents.
Srivenugopal KS; Shou J; Mullapudi SR; Lang FF; Rao JS; Ali-Osman F
Clin Cancer Res; 2001 May; 7(5):1398-409. PubMed ID: 11350911
[TBL] [Abstract][Full Text] [Related]
8. O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines.
Bobola MS; Silber JR; Ellenbogen RG; Geyer JR; Blank A; Goff RD
Clin Cancer Res; 2005 Apr; 11(7):2747-55. PubMed ID: 15814657
[TBL] [Abstract][Full Text] [Related]
9. O6-methylguanine-DNA methyltransferase (MGMT) transfectants of a 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-sensitive colon cancer cell line selectively repopulate heterogenous MGMT+/MGMT- xenografts after BCNU and O6-benzylguanine plus BCNU.
Phillips WP; Willson JK; Markowitz SD; Zborowska E; Zaidi NH; Liu L; Gordon NH; Gerson SL
Cancer Res; 1997 Nov; 57(21):4817-23. PubMed ID: 9354444
[TBL] [Abstract][Full Text] [Related]
10. Role of O6-alkylguanine-DNA alkyltransferase in protecting against 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced long-term toxicities.
Hansen RJ; Nagasubramanian R; Delaney SM; Cherian MM; Lin S; Kogan SC; Dolan ME
J Pharmacol Exp Ther; 2005 Dec; 315(3):1247-55. PubMed ID: 16126841
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived cells exhibiting lung epithelial cell characteristics are enriched in vivo using methylguanine DNA methyltransferase-mediated drug resistance.
Reese JS; Roth JC; Gerson SL
Stem Cells; 2008 Mar; 26(3):675-81. PubMed ID: 18192231
[TBL] [Abstract][Full Text] [Related]
12. Eradication of human medulloblastoma tumor xenografts with a combination of O6-benzyl-2'-deoxyguanosine and 1,3-bis(2-chloroethyl)1-nitrosourea.
Kokkinakis DM; Moschel RC; Pegg AE; Schold SC
Clin Cancer Res; 1999 Nov; 5(11):3676-81. PubMed ID: 10589786
[TBL] [Abstract][Full Text] [Related]
13. Extraneuronal monoamine transporter expression and DNA repair vis-à-vis 2-chloroethyl-3-sarcosinamide-1-nitrosourea cytotoxicity in human tumor cell lines.
Chen ZP; Remack J; Brent TP; Mohr G; Panasci LC
Clin Cancer Res; 1999 Dec; 5(12):4186-90. PubMed ID: 10632359
[TBL] [Abstract][Full Text] [Related]
14. Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity.
Marathi UK; Dolan ME; Erickson LC
Cancer Res; 1994 Aug; 54(16):4371-5. PubMed ID: 8044784
[TBL] [Abstract][Full Text] [Related]
15. O6-Methylguanine-DNA methyltransferase in pediatric primary brain tumors: relation to patient and tumor characteristics.
Bobola MS; Berger MS; Ellenbogen RG; Roberts TS; Geyer JR; Silber JR
Clin Cancer Res; 2001 Mar; 7(3):613-9. PubMed ID: 11297257
[TBL] [Abstract][Full Text] [Related]
16. Cellular resistance against the novel hybrid anthracycline N-(2-chloroethyl)-N-nitrosoureidodaunorubicin (AD 312) is mediated by combined altered topoisomerase II and O6-methylguanine-DNA methyltransferase activities.
Pawlik CA; Israel M; Sweatman TW; Lothstein L
Oncol Res; 1998; 10(4):209-17. PubMed ID: 9778692
[TBL] [Abstract][Full Text] [Related]
17. DNA repair enzyme, O6-methylguanine DNA methyltransferase, modulates cytotoxicity of camptothecin-derived topoisomerase I inhibitors.
Kuo CC; Liu JF; Chang JY
J Pharmacol Exp Ther; 2006 Feb; 316(2):946-54. PubMed ID: 16258022
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of O6-methylguanine DNA methyltransferase activity in patients with gastric cancer.
Dinçer Y; Akçay T; Tortum OB; Alademir Z; Onen S; Doğusoy G
Oncol Res; 2003; 13(4):205-9. PubMed ID: 12659421
[TBL] [Abstract][Full Text] [Related]
19. Tetrazepinones are equally cytotoxic to Mer+ and Mer- human tumor cell lines.
Jean-Claude BJ; Mustafa A; Watson AJ; Damian Z; Vasilescu D; Chan TH; Leyland-Jones B
J Pharmacol Exp Ther; 1999 Feb; 288(2):484-9. PubMed ID: 9918549
[TBL] [Abstract][Full Text] [Related]
20. Collateral sensitivity to nitrosoureas in multidrug-resistant cells selected with verapamil.
Futscher BW; Campbell K; Dalton WS
Cancer Res; 1992 Sep; 52(18):5013-7. PubMed ID: 1387586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
